- Home
- Equipment
- usa pennsylvania
- gene therapy s
Show results for
Refine by
Gene Therapy S Equipment Supplied In Usa Pennsylvania
11 equipment items found
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
Our investigational gene therapy, GT005, is designed to restore balance to a part of our immune system called the complement ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Identify an optimal formulation for your target cell line. Manufacturers of adeno-associated viral (AAV) vectors need to scale up quickly and cost-effectively to meet the increasing demand from the gene therapy market. But testing and optimizing multiple catalog media takes time and expertise. What if you had a panel of media and an expert in media optimization to help ...
Manufactured by:Polysciences, Inc. based inWarrington, PENNSYLVANIA (USA)
MAXgene GMP Transfection Reagent is a cGMP transfection reagent for the development and manufacturing of viral vectors for cell-and gene-based therapies. It is an ideal reagent in HEK293 and CHO systems for the manufacture of AAVs, LVs and recombinant proteins. MAXgene GMP capitalizes on the efficiency and scalability of Polysciences’ PEI MAX while adding the validation process and ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
Ocugen’s modifier gene therapy platform is a cutting-edge technology licensed from the Schepens Eye Research Institute of Massachusetts Eye and Ear (Harvard Medical School) and involves targeted delivery and expression of one or more nuclear hormone receptor genes (NHRs) in the disease tissues. ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU410 (AAV-RORA) is a modifier gene therapy product candidate being developed for the treatment of dry age-related macular degeneration (Dry AMD). OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA (RAR Related Orphan Receptor A) gene. Various genes associated with AMD are regulated by RORA. The RORA protein plays an important role in lipid metabolism and demonstrates ...
Manufactured by:XyloCor Therapeutics based inWayne, PENNSYLVANIA (USA)
XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or coronary artery bypass grafts become sedentary because of their symptoms and this can exacerbate comorbidities causing rapid deterioration of their health status and results in a poor quality of ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Cell Therapy Systems—a proven choice for clinical cell therapy manufacturing. As you move from basic cell therapy research to the clinic, high-quality GMP-grade cell therapy ancillary materials and proper documentation are essential to getting it right the first time. Cell Therapy Systems (CTS) products provide a proven choice for clinical stem cell therapy and immunotherapy research and ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
qPCR system for quantitation of residual plasmid DNA. Multiplex assay that targets all kanamycin resistance (KanR) gene alleles common in bioproduction. Highly specifi c quantitation through innovative DNA-free master mix. Highly sensitive quantitation using proven Applied Biosystems TaqMan real-time PCR technology. Reproducible results with manual and automated sample preparation, optimized for ...
Manufactured by:XyloCor Therapeutics based inWayne, PENNSYLVANIA (USA)
Coronary Artery Bypass Graft Surgery or CABG is a procedure used to treat coronary artery disease – the narrowing or blockage of the blood vessels that supply oxygen and nutrients to the heart muscle. During CABG, a healthy artery or vein from the body is connected, or grafted, to the blocked coronary artery. The grafted artery or vein bypasses the blocked portion of the coronary artery. ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU400 (AAV-NR2E3) is a novel gene therapy product candidate with the potential to be broadly effective in restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases (“IRDs”). It consists of a functional copy of a nuclear hormone receptor (“NHR”) gene, NR2E3, delivered to target cells in the retina using an adeno-associated ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
The Recombumin® product portfolio are the highest quality, animal and human origin-free recombinant human albumins commercially available. Our highly pure, safe and consistent albumins enable you to formulate with ...